Results 51 to 60 of about 2,016,996 (294)

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

Weight Control and Non-alcoholic Fatty Liver Disease: Evidence from China

open access: yesXiehe Yixue Zazhi, 2023
Based on the clinical trials and cohort studies in the Chinese population, this paper systematically summarized the association between weight/ body mass index (BMI) and their changes in preventing non-alcoholic fatty liver disease (NAFLD) and its ...
YANG Chenlu   +5 more
doaj   +1 more source

Weak values of electron spin in a double quantum dot

open access: yes, 2008
We propose a protocol for a controlled experiment to measure a weak value of the electron's spin in a solid state device. The weak value is obtained by a two step procedure -- weak measurement followed by a strong one (post-selection), where the outcome ...
Alessandro Romito   +4 more
core   +2 more sources

Impact estimates of nosocomial bloodstream infection : looking from a different angle [PDF]

open access: yes, 2011
Mortality associated with nosocomial bloodstream infection is multifactorial. Source of infection, etiology, age, underlying disease, acute illness, and appropriateness of antimicrobial therapy all contribute to the final outcome.
Vogelaers, Dirk   +2 more
core   +2 more sources

Adverse Outcomes in Pediatric Hypertension [PDF]

open access: yesHypertension, 2017
See related article, pp 1142–1147 It has been clear for decades that elevated blood pressure in adults is strongly associated with adverse cardiovascular disease outcomes,1 including myocardial infarction, cerebrovascular disease, and congestive heart failure.
openaire   +2 more sources

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High‐Risk Neuroblastoma: A Multi‐Institutional Retrospective Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...
Benjamin J. Lerman   +17 more
wiley   +1 more source

Prehospital tranexamic acid decreases early mortality in trauma patients: a systematic review and meta-analysis

open access: yesFrontiers in Medicine
BackgroundAs an anti-fibrinolytic agent, tranexamic acid (TXA) is widely recognized for its efficacy in managing hemorrhagic conditions. Prehospital application of TXA has been reported in recent years, but its benefits in trauma patients remain debated ...
Yi Li   +5 more
doaj   +1 more source

Feasibility of a randomized controlled trial of functional strength training for people between six months and five years after stroke: FeSTivaLS trial [PDF]

open access: yes, 2014
Background: Functional Strength Training (FST) could enhance recovery late after stroke. The aim of this study was to evaluate the feasibility of a subsequent fully powered, randomized controlled trial.
Barton, Garry R.   +10 more
core   +1 more source

The Efficacy and Safety of Bevacizumab/Irinotecan/Temozolomide (BIT) for Relapsed/Refractory Neuroblastoma: The UK Children's Cancer and Leukaemia Group Experience

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Patients with high‐risk neuroblastoma who either are refractory to induction chemotherapy or relapse following multi‐modal treatment have a dismal prognosis. Based on data from the BEACON trial, since 2021 the UK national guidelines recommend bevacizumab, irinotecan, and temozolomide (BIT) for patients with relapsed/refractory ...
Thomas J. Jackson   +20 more
wiley   +1 more source

Prediction Model for 30-day Outcomes Among Emergency Department Patients with Lower Gastrointestinal Bleeding [PDF]

open access: yes, 2020
Introduction: There are currently no robust tools available for risk stratification of emergency department (ED) patients with lower gastrointestinal bleed (LGIB).
Leafloor, Cameron   +3 more
core  

Home - About - Disclaimer - Privacy